Market Research Blog – Page 12973 – Just another WordPress site

Long-Acting Monoclonal Antibodies Market Overview by Top Players, Regions, Segments, Demand and Forecast till 2031

The Global Long-Acting Monoclonal Antibodies market study provides critical information related to the global, regional and top players including Long-Acting Monoclonal Antibodies market share analysis, winning strategies, recent developments, and financial planning. Besides providing information regarding the key players in the Long-Acting Monoclonal Antibodies market, the study also recalibrates, the impact of macroeconomic and microeconomic factors that has the potential to impact the growth of the Long-Acting Monoclonal Antibodies market.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

Understanding the Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

The FMI’s latest report on the Long-Acting Monoclonal Antibodies market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

Competitive Analysis

By Prominent Market Players

Eli Lilly
Abbott Laboratories
AstraZeneca plc.
Amgen Inc.
Bayer AG
Johnson & Johnson
Pfizer
GlaxoSmithKline Plc.
Merck & Co. Inc.
Novartis

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Long-Acting Monoclonal Antibodies market

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14105

Long-Acting Monoclonal Antibodies Market: Segmentation

By Source Type:

Murine
Chimeric
Humanized
Human

By Indication:

Cancer
- Breast cancer
- Colorectal cancer
- Lung cancer
- Ovarian cancer
- Others
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Others

By End User:

Hospitals Pharmacies
Drug Stores
Retail Pharmacies
E-commerce

Request For Table of Content @ https://www.futuremarketinsights.com/toc/rep-gb-14105

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Critical Questions Answered in the Report

What are ongoing trends that will shape market growth curve for global Long-Acting Monoclonal Antibodies market?
What are the drivers and challenges affecting the Long-Acting Monoclonal Antibodies market demand?
What are the recent technological advancement in the Long-Acting Monoclonal Antibodies market?
What are key trends and opportunities that will prevail the revenue growth of Long-Acting Monoclonal Antibodies market players?
How will evolving regulatory policies impact the market growth?
What is the impact of Covid-19 on the Long-Acting Monoclonal Antibodies market?

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the Long-Acting Monoclonal Antibodies market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Any Queries About Report, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb-14105

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Heating Pads Market is set to experience 6.5% growth during year 2021-2031

Due to surge in Changes in lifestyle of people, lack of exercises and prevalence of chronic pain stimulates industrial expansion of heating pads. Moreover, growing number of obese people and individual with sedentary lifestyle is growing across the globe, which further increase the possibility of chronic pain in different part of the body and its treatment with the help of the heating pad.

Heating Pads Market study by “Future Market Insights” provides details about the market dynamics affecting the market, Covid-19 Impact, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-14104

This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.

The report Heating Pads Market gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2018 to 2028 with respect to major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Heating Pads Market.

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting Heating Pads Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Leading Heating Pads Market Players:

Sunbeam
Carex
Thermalon
Milliard
Nature Creation
Beurer
Drive Medical
Kaz
Walgreens
Beady Heat Therapy

Key Elements that the report acknowledges:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-14104

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

IV Disinfecting Caps Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2031

The IV disinfecting caps market is said to grow steadily as the increase in number of hospital admissions and infections that can be easily affected to the people in it. Society for Healthcare Epidemiology of America (SHEA) and other top infection-control organizations in 2014 recognized the use of disinfection caps for hospitals.

IV Disinfecting Caps Market study by “Future Market Insights” provides details about the market dynamics affecting the market, Covid-19 Impact, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-14055

The report IV Disinfecting Caps Market gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2018 to 2028 with respect to major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the IV Disinfecting Caps Market.

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting IV Disinfecting Caps Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Leading IV Disinfecting Caps Market Players:

Phenomenome Discoveries Inc.
Human Metabolome Technologies, Inc.
Thermo Fisher Scientific, Inc.,
Bio- Rad Laboratories, Inc.
Biocrates Life Sciences AG
Agilent Technologies, Inc
Merit Medical
BD
3M

Key Elements that the report acknowledges:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-14055

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

SGLT2 Inhibitors Treatment Market Emerging Growth Analysis, Future Demand and Business Opportunities 2031

SGLT2 Inhibitors Treatment market players – Eli Lilly and Company (The U.S), C.H. Boehringer Sohn AG & Ko. KG (Germany), Johnson & Johnson (The U.S), AstraZeneca plc (UK), The Merck Group (Germany), Pfizer Inc. (The U.S), Tecnimede Group (The U.S), Unichem Laboratories Ltd. (India), and Edifício Bluepharma (Portugal), among others represent the global SGLT2 Inhibitors Treatment market. The market study depicts an extensive analysis of all the players running in the SGLT2 Inhibitors Treatment market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the SGLT2 Inhibitors Treatment market report.

Future Market Insights, in its latest business report, elaborates on the current situation of the global SGLT2 Inhibitors Treatment market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects.

Understanding the Impact of Covid-19 on Healthcare Industry

The FMI’s latest report on the SGLT2 Inhibitors Treatment market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

Request For Table Of Content @ https://www.futuremarketinsights.com/toc/rep-gb- 14054

Critical Questions Answered in the Report

What are ongoing trends that will shape market growth curve for global SGLT2 Inhibitors Treatment market?
What are the drivers and challenges affecting the SGLT2 Inhibitors Treatment market demand?
What are the recent technological advancement in the SGLT2 Inhibitors Treatment market?
What are key trends and opportunities that will prevail the revenue growth of SGLT2 Inhibitors Treatment market players?
How will evolving regulatory policies impact the market growth?
What is the impact of Covid-19 on the SGLT2 Inhibitors Treatment market?

SGLT2 Inhibitors Treatment Market: Segmentation

By Product Type:

Single Cap
Double Cap

By End User:

Hospitals
Clinics
Diagnostic Centre’s
Others

By Application:

Blood Collection,
Blood Transfusion
Infusion

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

The SGLT2 Inhibitors Treatment market research gets rid of the following queries:

How the market for SGLT2 Inhibitors Treatment is expected to shape in the coming ten years?
What strategies are the SGLT2 Inhibitors Treatment market vendors implementing to stay ahead of their rivals?
Why are consumers shifting towards alternative SGLT2 Inhibitors Treatment products?
What innovative technologies are the SGLT2 Inhibitors Treatment players using to get an edge over their rivals?
What are the restraints affecting the growth of the global SGLT2 Inhibitors Treatment market?

Any Queries Regarding Report, Speak To Analyst @ https://www.futuremarketinsights.com/askus/rep-gb- 14054

Reasons to Buy the report

We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.

The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the SGLT2 Inhibitors Treatment market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Request Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14054

About Future Market Insights (FMI)

U.S. Compounding Pharmacies Market is projected to exceed US$ 4.64 Bn over 2028

U.S. Compounding Pharmacies Market is projected to exceed US$ 4.64 Bn and is expected to grow at over 5.1% CAGR between 2022 and 2028. Increasing focus on introducing innovative formulations to combat several diseases is driving the growth in the market.

According to a recent research by Future Market Insights (FMI), the global compounding pharmacies market is estimated to have accounted around US$ 8 Bn in terms of value during 2018. The report on the U.S. compounding pharmacies market also projects that the market will grow at a CAGR of approximately 5% during the period 2018-2028.

The U.S. compounding pharmacies market revenue is expected to increase at a robust growth rate over the next few years despite the reporting of several adverse events and drug mismanagement-related deaths. The U.S. compounding pharmacies market is expected to gain popularity in several regions of the U.S. due to upcoming products and therapeutic areas that are yet to be tapped by branded manufacturers. Focus on factors, such as the availability of drugs in innovative medium/forms and the administration of varying dosages for various indications, is expected to drive the adoption of newer dosage forms of compounded medications.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-us-978

Market Remains Influenced by Availability of Compounded Pain Management Drugs

The growing popularity of pain management therapies is fuelling the growth of U.S. compounding pharmacies market. Compounded pain management drugs are not FDA-approved, however, they come under the State Pharmacies Board supervision in the U.S. For example, medical guidelines such as the Chronic Pain Guidelines stated by the Medical Treatment Utilization Schedule (MTUS) do not support the use of compounds such as Gabapentin and Baclofen for pain management. However, compounding pharmacies use these compounds as well as several others in varying strengths to attract customers and increase their revenue.

Moreover, an increase in the shortage of prescription medicine is expected to upsurge the demand for compounding pharmacies. According to the U.S. FDA, only 154 drugs were in short supply or not available in 2007, as compared to 456 in 2012. Currently, the number of drugs in short supply is around 300. Medicinal drought is prominent in the U.S. as compared to other countries, which is also fuelling the revenue growth of the U.S. compounding pharmacies market.

On the other hand, increasing regulatory pressures are expected to hamper the growth of the U.S. compounding pharmacies market. Compounding pharmacies are engaged in trans-boundary drug compounding, and the manufacturing of bulk drugs & ingredients need to be registered with the FDA, undergo mandatory inspections, and abide by GMP guidelines. For instance, the FDA has stated that around 70% of registered firms have been inspected, of which 28 firms have been issued FDA Form 483s (non-adherence to cGMP regulations and unsafe compounding practices), and five warning letters, which implies a very high rate of action. Compounding pharmacies registering with the FDA could serve to increase credibility. However, inspections and compliance with good manufacturing practices is compulsory. Regulatory pressures on compounding pharmacies are expected to force the smaller ones to close their business primarily due to unsafe compounding practices, which are likely to directly impact patient safety.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-us-978

Hormone Replacement Therapeutic Area to Hold over 38% Revenue Share in Market

By product type, oral medication is the expected to dominate the U.S. compounding pharmacies market in term of revenue, which is then followed by topical medication. The injectable segment by product type of the U.S. compounding pharmacies market is projected to grow at a significant rate as compared to other segments. The hormone replacement therapy segment is the leading segment in terms of revenue among all the therapeutic area segments of the U.S. compounding pharmacies market, and is estimated to gain a 38.4% revenue share in 2019.

Among the pharmacy type segments, the 503A pharmacy segment is expected to gain a major revenue share as compared to the 503B pharmacy segment over the forecast period. By application, the adults segment is estimated to dominate the U.S. compounding pharmacies market, followed by the paediatrics segment. The veterinary segment is expected to grow at a faster pace as compared to the other application segments of the U.S. compounding pharmacies market.

The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy, Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Millers Pharmacy, Centene Corporation, Infinity Care Solutions, Triumph Pharmacy, and Sixth Avenue Medical Pharmacy.

Why Future Market Insights?

? Comprehensive analysis on evolving purchase pattern across different geographies

? Detailed insights of market segments and sub-segments for historical as well as forecast period

? A competitive analysis of prominent players and emerging players in the keyword market

? Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/978

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Pressotherapy Systems Market 2022 Strategic Analysis, Growth Drivers, Industry Trends, Demand And Future Opportunities Till 2027

Pressotherapy Systems Market Overview

Pressotherapy is a method related to lymphatic waste and cellulite. It is a new idea yet its appearing to have many advantages, in the evacuation of fat as well as in more different treatment ranges, for example, tattoo removal. It offers the customer solutions for lymph seepage, lessening of cellulite, expanded fat digestion and developed for efficient removal of the tattoo. Pressotherapy is conveyed by PC controlled pressure frameworks that generate loads of air situated around the appendages. The chambers inflate sequentially to help push fluid towards the lymphatics and increase draining. This also improves the venous flow around the body. The result of this sequential massage is to assist clear fluid like edema and reduce swelling. Pressotherapy is an excellent treatment on its own but can also be combined with other treatments to increase its lipo-laser and acoustic wave therapy. Pressotherapy is a treatment that is calibrated and constant weighted rubbing or massage that advances the physiological seepage of interstitial liquid and circulation of blood. The gadget blows up specific pneumatic structures (bladders) that having a flawless anatomical correspondence, wrap appendages and abdomen. The bladders are fuelled by an electronic compressor keeping in mind the end goal to make a peristaltic wave that moves in the distal-proximal bearing in the flow of the fluid stream.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-3668

The circulatory framework is an arrangement of vessels that contains and moves some body Fluids i.e. from the blood in blood circulatory framework and the lymph in a lymphatic framework. The bladders comprise of parallel fragments that are deflated and inflated in a successive way guaranteeing a unidirectional stream, without interference or stagnation. The groupings are composed of cycles of a brief span. The weights connected to each portion, can vary from case to case, be that as it may, it must not surpass the circulatory strain, to keep away from harm to the physiological course. The lymph seepage advances blood course encouraging the expulsion of catabolites and waste from the extracellular condition and guaranteeing the supply of new supplements.

Pressotherapy Systems Market: Drivers and Restraints

The key contributor to the growth of global Pressotherapy systems includes increasing number of lipo-laser and acoustic wave therapy owing to sedentary lifestyle and expanding elder population base. Poor dietary habits and fluid intake, increasing obesity levels and rising caseload of metabolic disorders may fuel the rate of market growth. Advancements in Pressotherapy system composition materials leading to minimize patient discomfort and give new favor to the market. Availability of innovative smartphone applications has boosted the growth of the market for Pressotherapy systems management and patient safety, which are useful for both physicians and patients.

Pressotherapy Systems Market: Overview

Global Pressotherapy systems market is consolidated with a several players. HEAT Spa Kur Therapy Development Inc., Unmanned Aircraft Systems, Guangzhou Creatbeauty Technology Co., Ltd., Doris Electronic Technology Co., Ltd are some of the key global players in the market. Chinese players have a major share in the Asia Pacific market owing to increasing number of emerging Pressotherapy systems manufacturers and growing demand for the therapy.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-3668

Pressotherapy Systems Market: Region-wise Outlook

Geographically, Pressotherapy systems market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. Developed markets like North America and Europe are expected to witness robust growth due to increasing demand and presence of the main global players in the region. Asia Pacific is projected to register positive growth owing to favorable patient demographics and developing healthcare infrastructure in the region. The lack of healthcare infrastructure and insufficient proper training is expected to impact the Pressotherapy systems market in Africa negatively.

Pressotherapy Systems Market: Key Players

The key players in the global Pressotherapy systems market include DJO Global, Inc., Bio Matrix, Elettronica Pagani Srl, Devon Medical Products Inc., Novasonix Technology Sl., HEAT Spa Kur Therapy Development Inc., Unmanned Aircraft Systems, Guangzhou Creatbeauty Technology Co., Ltd., Doris Electronic Technology Co., Ltd and many more.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil and Rest of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
Eastern Europe (Poland, Russia and Rest of Eastern Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request for Pre Book of Report: https://www.futuremarketinsights.com/checkout/3668

Pressotherapy Systems Market: Segmentation

Global Pressotherapy systems market has been segmented on the basis of application, end-user, and region.

Based on the application, the global Pressotherapy systems market is segmented into:

Veno-lymphatic circulation
Cellulite at different stages
Adiposity edema
Reduction of swelling
Tired legs
Lymphatic drainage
Re-modelling
Skin elasticity

Based on the end user, Pressotherapy Systems Market is segmented into the following:

Hospitals
Specialty Clinics

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Teleradiology Market poised to increase at an impressive CAGR of 12.18% during the forecast period 2021-2031

As per a study by ESOMAR-certified consulting firm Future Market Insights (FMI), the global teleradiology market is expected to surpass a valuation of US$ 5.15 Bn through 2021. Favored by the increasing number of medical imaging procedures such as computed tomography (CT) scans and X-ray scans, the sales of teleradiology are likely to surge at a vigorous 12.18% CAGR during the assessment period.

Rising prevalence of diseases such as cancer, arthritis, cellulitis, and osteomyelitis are facilitating the market growth. According to the National Institute of Cancer, around 1898,160 new incidences of cancer are estimated to be diagnosed in 2021, causing approximately 608,570 deaths in the U.S.

As teleradiology enables the transfer of radiological images to qualified radiologists for providing effective treatments, it plays a life-saving function for patients. Thus, with the increasing number of cancer cases and lack of availability of skilled radiologists in sub-urban and rural areas, the demand for teleradiology systems is likely to increase over the coming year.

The coronavirus outbreak has favored the teleradiology market by increasing demand for medical imaging procedures across the globe. As the use of teleradiology systems avoids in-person contacts for the exchange of hard imaging result copies, these systems are increasingly being adopted by hospitals, medical institutes, and clinics for sharing study observations and details information gathered, thereby, driving teleradiology sales.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1747

“Key players in the market are integrating novel technologies such as artificial intelligence (AI), cloud-based solutions, and picture archiving and communication system (PACS) for developing innovative teleradiology solutions as they aim at capitalizing on the increasing demand of accurate diagnosis,” says the FMI’s analyst.

Key Takeaways from FMI’s Teleradiology Market Study

Sales of teleradiology systems are expected to rise at 9.10% between 2020 and 2021.

The U.S. is estimated to dominate the North America teleradiology market owing to the presence of leading market players in the country.
China is likely to emerge as the prominent market in Asia Pacific due to the high prevalence of chronic diseases such as cancer and arthritis.
Based on modality, CT scans are anticipated to lead the segment, on the back of rising digitalization and technological advancements in the segment.
Owing to the surging demand for diagnostic imaging procedures due to the lack of qualified radiologists, ambulatory imaging centres (AICs) are expected to account for substantial revenue share.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-1747

Competitive Landscape

Teleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings, Inc., Vital Radiology Services, and Telemedicine Clinic are the leading players operating in the teleradiology market as profiled by FMI.

The teleradiology market is highly fragmented owing to the presence of large number of market players. Leading player emphasizing on launching the new products and expanding their product portfolio to gain competitive edge over other player. Besides, this some of the players are adopting strategies such as strategic collaboration, merger, acquisition, and partnership with other industry players to strength their market footprint. For instance,

In February 2021, Medica Group, teleradiology provider headquartered in the U.K. announced entering in a joint venture partnership with MedX, a Canada-based pharmaceutical logistics and supply chain company. The strategy will help the Medica Group providing teleradiology reporting service in New Zealand, Australia, and Ireland
Recently Vital Radiology Services, an international teleradiology service provider company headquartered in India, announced entering into a partnership with one the largest medical imaging providers in the world, I-MED Radiology Network. This partnership will assist both the companies to bring innovation in the domain to a new level.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-1747

More Insights into the Teleradiology Market Report

In its latest report, FMI offers an unbiased analysis of the global teleradiology market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of modality (X-Ray scans, CT scans, MRI scans, ultrasound scans, nuclear scan, cardiac echo, mammography, and electromammography), and end user (hospitals, clinics, ambulatory surgical centres, and radiology centres), across U.S. and Other than U.S. (Latin America, Europe, Asia Pacific excluding Japan, Japan, and Rest of the World)

Mycobacterium Tuberculosis Testing Market Research Report: Overview With Geographical Segmentation By Revenue With Forecast 2029

Tuberculosis is an infectious disease caused by mycobacterium tuberculosis and mainly affects the lungs. Tuberculosis is a communicable disease and can be easily transmitted from one person to another through cough and sneezes. Tuberculosis is categorized into two type’s namely as active tuberculosis and latent tuberculosis. The common site of infection are lymph node, joints and bones, pulmonary, etc. According to the report published by WHO in 2018 tuberculosis is one of the top 10 deadliest disease and causes annual death of 1.6 million people worldwide.

The increasing demand for more advanced and better diagnostic procedure of tuberculosis is creating new opportunities for market players especially in the emerging economic countries. According to the WHO report, 54 million lives had been saved through tuberculosis diagnosis and through proper treatment between the years 2000 and 2017.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-10259

Mycobacterium Tuberculosis Testing Market: Drivers and restraints

Rising prevalence of tuberculosis across the globe is one of the major factor affecting the mycobacterium tuberculosis testing market. Increasing awareness of people towards infectious diseases like tuberculosis is further aiding in the growth of the mycobacterium tuberculosis testing market.

Various initiatives taken by local government and NGO’s is expected to boost the growth of the mycobacterium tuberculosis market. Increasing adoption of tuberculosis diagnostic kit for early detection of the tuberculosis is further supporting the growth of the mycobacterium tuberculosis testing market. Furthermore, the increasing research and development activities for developing better testing procedures is expected to surge the mycobacterium tuberculosis testing market. New and advanced technology for accurate detection of tuberculosis is anticipated to drive the growth of the target market. However, high cost of the diagnosis and time consumption are the restraints expected to hamper the growth of the mycobacterium tuberculosis testing market. Also, requirement of specialized equipment for testing procedure may limit the growth of the mycobacterium tuberculosis testing market.

Mycobacterium Tuberculosis Testing Market: Overview

Mycobacterium tuberculosis testing market is expected to have a tremendous growth in the near future. Recent studies have shown that tuberculosis cases is falling at the rate of 2% every year and is estimated to have annual decline of 4-5% over the forecast period. Based on tests type, culture based test type segment is leading the mycobacterium tuberculosis testing market as it gives very accurate diagnosis of the tuberculosis. Among the end-user, the specialty clinic segment is contributing the major market share in terms of revenue.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-10259

Mycobacterium Tuberculosis Testing Market: Regional Outlook

North America is anticipated to have a significant market share in terms of revenue in the mycobacterium tuberculosis testing market. This is attributed to the increasing prevalence of tuberculosis cases and intensive research activities in the region. Europe is expected to score second prominent market share in the mycobacterium tuberculosis testing market, owing to the increasing awareness of people towards infectious diseases like tuberculosis. Also, improved healthcare infrastructure and reimbursement in policies are further expected to pool the mycobacterium tuberculosis testing market. Asia Pacific is projected to witness the lucrative growth in the near future. The rising cases of tuberculosis especially in developing countries of the region and increasing awareness of people for early diagnostic and treatment of the tuberculosis is contributing in the growth of the mycobacterium tuberculosis testing market. Also several government initiatives and higher disposable income of the region is further driving the mycobacterium tuberculosis testing market. Latin America is expected to experience a stable growth whereas MEA expected to be the least lucrative market due to lower adoption.

Mycobacterium Tuberculosis Testing Market: Key Players

The major players operating in mycobacterium tuberculosis testing market are Thermo Fisher Scientific, Cepheid Inc. (Danaher Corporation), Medical Innovation Ventures Sdn. Bhd (Mediven), ELITechGroup, DAAN Gene Co., Ltd, AccuQuik, RTA Laboratories, Osang Healthcare CO., Ltd, Hologic, Inc., F. Hoffmann-La Roche AG., Abbott Laboratories, Novacyt Group, and Akonni Biosystems Inc..

The report on Mycobacterium tuberculosis testing market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report on Mycobacterium tuberculosis testing market provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report on Mycobacterium tuberculosis testing market also maps the qualitative impact of various market factors on market segments and geographies

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-10259

Mycobacterium Tuberculosis Testing Market: Segmentation

The mycobacterium tuberculosis testing market is segmented on the basis of test type, end-user

Based on test type, the mycobacterium tuberculosis testing market is segmented into

Culture Based Tests
Nuclear Acid Amplification Tests
GeneXpert MTB/RIF 11
Line Probe Assay (LPA) 13
Loop-Mediated Isothermal Amplification (LAMP)
Smear Microscopy
Mantoux Test or Tuberculosis Skin Test
Interferon Gamma Release Assays (IGRAs)
Point of Care Test
Others

Based on end-user, the mycobacterium tuberculosis testing market is segmented into

Hospitals
Specialty Clinics
Diagnostic Laboratories
Others

Hemostat Market is expected to expand at a CAGR of 5.8% over 2016–2025

Demand for hemostats in India will be worth 56.7 Mn in 2016, up from US$ 54.1 Mn in 2015. Growth will be led by steady demand for mechanical hemostats, such as sponges, gauzes, strips, and films. Mechanical hemostats will account for 88.4% revenue share of the market in 2016.

Adoption of hemostats that reduce post-operative time and increase in complex surgeries will continue to create sustained demand for hemostats. Rising awareness, combined with favourable reimbursement policies will carry forward the momentum in 2016 and beyond.

Gelatin will continue to witness higher demand vis-à-vis oxidised cellulose, owing to its higher blood absorption properties. The gelatine product material segment will generate revenues worth 43.8 Mn in 2016, witnessing a y-o-y increase of 5.0% over 2015.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-IN-1518

Surgeries and trauma cases remain the two leading application areas of hemostats. Revenue share of surgery segment is expected to reach 63.5% in 2016, representing market value of 36 Mn. Use of hemostats is growing in trauma cases, with this segment poised to witness an impressive growth rate in the future.

Hospitals will continue to remain the leading distribution channel for hemostats in 2016, generating 22.8 Mn in revenues. Favourable reimbursement policies, combined with increasing adoption of hemostat products by medical practitioners and surgeons will continue to fuel demand in 2016. Sales of hemostats through e-commerce channel are also expected to witness an increase in 2016, witnessing a y-o-y increase of 4.3% over 2015.

Browse the full “Hemostat Market: India Industry Analysis and Opportunity Assessment 2016 – 2025” market research report at https://www.futuremarketinsights.com/reports/india-hemostat-market

Ethicon, LLC, Eucare Pharmaceuticals (P) Ltd., Mil Laboratories, and Aegis Lifesciences are the top 4 players in the India hemostat market. The key strategy of the leading players is to market economical products as end users are opting for cheaper alternative in India.

Long-term Outlook: FMI maintains a positive long-term outlook on the India hemostat market and estimates global revenues to increase at 5.8% CAGR during the forecast period 2016-2025.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-IN-1518

Key Segments Covered

Segmentation on basis of Product Type

Mechanical type
Flowable type

Segmentation on basis of Product Material Base

Gelatin
Oxidized cellulose

Segmentation on basis of Application

Surgery
Trauma cases

Segmentation on basis of Distribution Channel

Hospitals
Ambulatory Surgical Centers
Clinics
Online Channels

Segmentation on basis of Geography
India

Breast Pumps Market expected to grow at approximately 4% through 2030

FMI, an ESOMAR-certified market research firm, states that the global breast pump market will be valued at US$ 1.5 Bn in 2020. During the forecast period (2020-2030), the market is likely to grow at a CAGR of 4%.

The world of infant feeding has been witnessing a “quiet revolution” since 2005. The usage of electric pumps has increased manifold since then. Initially it was confined only to mothers of premature babies in the NICU, but the current scenario is such that even full-term infants are being fed through pumped milk.

This could be attributed to the fact that awareness regarding breast pumps is increasing day after day in the developed economies, US in particular.

Even in the European economies, the electric breast pumps are being made available on rent. So, regular usage as well as occasional usage gets sufficed. These usages are likely to substantiate the breast pumps market in the forecast period (2020-2030).

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5820

In the US, the “Affordable Care Act” states that the breast pump’s cost is 100% reimbursable, and it’s mandatory for the employers to provide space and time for the working moms to pump.

In developing economies like India, the usage of breast pumps is catching up in the metros as there are more women falling under the gambit of corporate world. As such, Asia Pacific will soon witness an exponential growth in breast pumps market in the next 10 years.

Key Takeaways of Breast Pump Market Study

Open system breast pumps held the largest market share in 2019
By technology, electric breast pumps accounted for the highest revenue in 2019
Cumulatively, North America and Europe contributed for more than 60% of market share 2019 and the trend is expected to continue going forward as well

“Breast pump, a gift of advanced medical technology, and bliss for working mothers, which is resulting in growing adoption. Moreover, increasing promotional campaigns are likely to boost the growth of breast pump market.” says the FMI Analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5820

Human Milk Banks: A Catalyst to Breast Pumps Market

Late pregnancies are proving to be detrimental to breast-feeding. In other words, late pregnancies often result in women not being able to lactate. As per the WHO, mother’s milk is imperative atleast for the first six months as it helps in building immunity. However, for infants whose mothers’ mammary glands are unable to produce milk or mother is suffering from an ailment wherein it can’t be passed on to the infant; human milk banks are the solution.

Donors need to inform the human milk banks. The banks then send breast pumps to the donors so that they can extract the milk and store it in bottles. Then the same milk is collected by the banks and given to those needy infants. Human Milk Banking Association of America has been actively serving in this regard. Right now, Covid-19 infected mums can’t pass on their milk to the infants. Milk from the milk banks helps over here. Elvie had offered “milk shuttle service” at CES 2020; wherein they used to collect milk from mums who attended the show and ensure safe storage by having them placed in medical-grade refrigerators.

In India, there are 14 human milk banks right now. Milk banks are expected to be a key growth driver in the upcoming period.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-5820

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global breast pump market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on breast pump market on basis of product type (closed system breast pumps, open system breast pumps), technology (electric breast pumps, manual breast pumps), end user (homecare settings, healthcare facilities) across seven major regions.